A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS. (June 2017)

• Record Type: Journal Article
• Authors: Ying, Z.; Xiang, X.; Song, Y.; Ding, N.; Lin, Y.; Zheng, W.; Wang, X.; Lin, N.; Tu, M.; Xie, Y.; Zhang, C.; Liu, W.; Deng, L.; Liu, Y.; Yue, Y.; Yu, X.; Liu, H.; Duan, P.; Chen, F.; Wu, X.; Huang, X.F.; Jones, L.; Kang, X.; Chen, S.; Zhu, J.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 262
• Page End: 262
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_131
• Languages: English
• ISSNs: 0278-0232